ZA93928B - Antiviral antibody - Google Patents

Antiviral antibody

Info

Publication number
ZA93928B
ZA93928B ZA93928A ZA93928A ZA93928B ZA 93928 B ZA93928 B ZA 93928B ZA 93928 A ZA93928 A ZA 93928A ZA 93928 A ZA93928 A ZA 93928A ZA 93928 B ZA93928 B ZA 93928B
Authority
ZA
South Africa
Prior art keywords
antiviral antibody
antiviral
antibody
Prior art date
Application number
ZA93928A
Inventor
James Scott Crowe
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZA93928B publication Critical patent/ZA93928B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
ZA93928A 1992-02-11 1993-02-10 Antiviral antibody ZA93928B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929202796A GB9202796D0 (en) 1992-02-11 1992-02-11 Antiviral antibody

Publications (1)

Publication Number Publication Date
ZA93928B true ZA93928B (en) 1994-08-10

Family

ID=10710132

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA93928A ZA93928B (en) 1992-02-11 1993-02-10 Antiviral antibody

Country Status (4)

Country Link
AU (1) AU3459593A (en)
GB (1) GB9202796D0 (en)
WO (1) WO1993016192A1 (en)
ZA (1) ZA93928B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060257890A1 (en) * 1996-05-20 2006-11-16 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6165793A (en) * 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6309883B1 (en) 1994-02-17 2001-10-30 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
IL118626A0 (en) 1996-06-11 1996-10-16 Xtl Biopharmaceuticals Limited Anti HBV antibody
US6153410A (en) * 1997-03-25 2000-11-28 California Institute Of Technology Recombination of polynucleotide sequences using random or defined primers
GB9712512D0 (en) 1997-06-16 1997-08-20 Bioinvent Int Ab A method for in vitro molecular evolution of protein function
DE19980730D2 (en) * 1998-04-28 2001-05-10 Wolfgang Bergter Radioimmunopharmaceuticals for the treatment of hepatitis C
KR100345463B1 (en) * 1998-11-19 2003-01-08 주)녹십자 Preparation of humanized antibody on surface antigen pre-s1 of hepatitis b virus
WO2001023592A2 (en) 1999-09-27 2001-04-05 Genentech, Inc. Methods for making recombinant proteins using apoptosis inhibitors
KR100484054B1 (en) * 2000-10-02 2005-04-20 한국생명공학연구원 A humanized antibody to surface antigen S of hepatitis B virus and a preparing method thereof
JP2004517636A (en) * 2000-10-02 2004-06-17 コリア リサーチ インスティテュート オブ バイオサイエンス アンド バイオテクノロジー Humanized antibody against surface antigen S of hepatitis B virus and method for producing the same
US6958213B2 (en) 2000-12-12 2005-10-25 Alligator Bioscience Ab Method for in vitro molecular evolution of protein function
US20020086292A1 (en) 2000-12-22 2002-07-04 Shigeaki Harayama Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules
GB201114858D0 (en) 2011-08-29 2011-10-12 Nvip Pty Ltd Anti-nerve growth factor antibodies and methods of using the same
AU2012252152B2 (en) 2011-05-06 2016-07-07 Zoetis Services Llc Anti-nerve growth factor antibodies and methods of preparing and using the same
US9580496B2 (en) 2011-05-06 2017-02-28 Nexvet Australia Pty Ltd Therapeutic canine immunoglobulins and methods of using same

Also Published As

Publication number Publication date
AU3459593A (en) 1993-09-03
GB9202796D0 (en) 1992-03-25
WO1993016192A1 (en) 1993-08-19

Similar Documents

Publication Publication Date Title
DE69307690D1 (en) Implantierbare penis-prothese
DE69319731D1 (en) Wässrige polyurethan-dispersionen
AU115931S (en) Cuff-link
DE59302394D1 (en) Linearlagerelement
DE69306746D1 (en) Schlichtmittelzusammensetzung
EP0563714A3 (en) Tnf-muteins
GB9202796D0 (en) Antiviral antibody
DE69310500D1 (en) Racemisierungsverfahren
IL100841A0 (en) Immunoassay
EP0556141A3 (en) Air-filtration-module
AU116869S (en) Bottle-cooler
DE69327712D1 (en) Custardkreme
DE69318966D1 (en) Chemilumineszenzverstärker
DE69321365D1 (en) Polyacetalharzzusammensetzung
DE69315037D1 (en) Phasendifferenz-kompensationsfilm
GB9215096D0 (en) Bikelox
AU116434S (en) Sponge-squeegee
GB9115010D0 (en) Antibody
GB9215176D0 (en) Antiviral combinations
GB9222573D0 (en) Antibodies
GB9207192D0 (en) Antibodies
GB9214409D0 (en) Antiviral agents
CA71063S (en) Montre-chronographe
CA70408S (en) Hairsetter
AU499P (en) BAYAMO Desmanthus virgatus